Covaxin row: Bharat Biotech clarifies allegations over volunteer who died after shot

After a participant who allegedly died days after volunteering for Covaxin trial in Bhopal, Bharat Biotech on Saturday clarified that the volunteer, at the time of enrolment, had fulfilled all the inclusion and exclusion criteria to be accepted as a participant in the Phase III trial and was reported to be healthy in all the […]

COVID-19 vaccines ‘Covishield’, ‘Covaxin’ to be available soon in India

Union Health Minister Dr Harsh Vardhan on Thursday said that the COVID-19 vaccines ‘Covishield’ and ‘Covaxin’ are on the verge of being available in the country. The Health Minister while addressing a press conference, said, “COVID-19 vaccines ‘Covishield’ and ‘Covaxin’ are on the verge of being available in the country. Our efforts are to ensure […]

Covaxin is 200% safe, says Bharat Biotech Chairman

Covaxin, the indigenous vaccine developed by Bharat Biotech against COVID-19 in collaboration with ICMR, is 200 percent safe, company’s Chairman and Managing Director Dr Krishna Ella has said and noted that it has shown less than 10 percent adverse reaction in trials so far. “Covaxin has shown less than 10 percent adverse reactions, while others […]

Bharat Biotech setting up four vaccine manufacturing facilities

Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, on Monday said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per annum. Denying allegations that the city-based vaccine maker lacks data of Covaxin, Krishna Ella, chairman of Bharat […]

Covaxin can work against mutated coronavirus: Bharat Biotech

Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Director of the city-based vaccine maker Krishna Ella said on Tuesday. He also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration with […]

India’s indigenous coronavirus vaccine ‘Covaxin’ shows robust immune response in 1st phase clinical trials

India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials. A detailed immunogenicity response of the first phase trials of the vaccine has been declared by the manufacturers. Covaxin, jointly developed by Hyderabad-based Bharat Biotech and ICMR has been found to be safe generating no serious adverse […]

AIIMS administers first dose of COVID-19 candidate vaccine `Covaxin’ to 30-year-old Delhi resident

The All India Institute of Medical Sciences (AIIMS) on Friday administered the first dose of country’s first indigenous vaccine candidate `Covaxin’ to a 30-year-old man as part of efforts to combat COVID-19. This is the first phase of human clinical trial after the institute’s ethics committee gave its approval for the trail for the indigenously […]